Biotechnology News Magazine

03/13/2024

https://youtu.be/oQYYLcvbRrY?si=5HErAwp02rOd_Ixw

What’s in the Box??? (A Shipping GAME CHANGER)Here is his FB profile: https://www.facebook.com/MikeyMayez?mibextid=ibOpuVOr email him here: mmayer@eleventedi...

03/04/2024

Howard Robin, President and Chief Executive Officer of Nektar Therapeutics: "We are pleased to bring on TCGX as a new high-quality, long-term investor in Nektar as we advance rezpegaldesleukin through our Phase 2b studies in atopic dermatitis and alopecia areata. We are on track to report topline da...

02/15/2024

Argonne reports he project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE.

02/15/2024

CEO of Tevogen Bio. said, “We are excited to begin our journey as a public company with this additional investment.

02/14/2024

Overall, online medical administrative assistant programs offer many benefits like convenience, lower costs, self-paced learning, and preparation for an in-demand career. Read on.

02/14/2024

This new collaboration is another example of Blacksmith's creative deal-making with top tier partners that bring expertise to the table which helps de-risk and accelerate scientific discoveries for the development of valuable products.

02/13/2024

Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection 1,000 mL (2 units/mL) by B. Braun.

02/07/2024

Anna Kazanchyan, MD, Founder and CEO of Saghmos Therapeutics. "We are very pleased to announce the Notice of Allowance for our second patent, which will enhance the long-term value of ST-62516. Saghmos continues to build its intellectual property estate."

02/07/2024

SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain.

02/05/2024

The Callisto™ Sample Prep System offers programmable, precise, and plastic-free liquid manipulation with pre-optimized applications to support short- and long-read sequencing workflows. With a growing menu of library prep kits powered by Watchmaker Genomics' solutions, Volta Labs will continue to ...

02/05/2024

BDC Laboratories describes GOA analysis as a multi-dimensional imaging challenge because heart valve substitutes have complex geometries and perform nuanced movements.

01/04/2024

“I am so excited about the future of small molecule drug discovery and X-Chem’s role in that future,” said incoming CEO Karen Lackey. “In my first six months at X-Chem, I have seen top-tier science and met many amazingly talented scientists. Together, we can continue to bring incredible inno...

11/22/2023

The creation of CAR T cell therapy begins with collection of the patient’s blood and separation of the lymphocytes. These include T cells, B cells, and innate lymphoid cells, all of which are separated through apheresis (leukapheresis). It is this separation process which, if optimized, has the po...

11/21/2023

News regarding Genentech and NVIDIA Enter Into Strategic AI Research Collaboration

10/31/2023

“This acquisition will provide a much-needed treatment to patients in need,” said Orlaith Ryan, chief technical officer and co-founder of Shorla Oncology. “It brings a crucial oral treatment to a larger patient population who suffer from cancer and other debilitating illnesses.”

10/31/2023

Anticipated to be the first CDH17 CAR T cell therapy to enter the clinic. Phase 1A clinical trial to initiate patient enrolment in 2024. Phase 1A clinical trial will enroll patients with advanced Colorectal Cancer, Gastric Cancer and Neuroendocrine Tumours.

10/31/2023

This technology presents a safer alternative to traditional biopsies for patients facing challenges in accessing affected tissue without surgical intervention, as seen in cases like lung cancer. It is particularly beneficial for elderly patients, for whom a lung tissue biopsy may not be suitable due to the potential for severe complications associated with it.

This technology presents a safer alternative to traditional biopsies for patients facing challenges in accessing affected tissue without surgical intervention, as seen in cases like lung cancer. It is particularly beneficial for elderly patients, for whom a lung tissue biopsy may not be suitable due...

10/23/2023

She writes, "Collecting patient-reported outcome (PRO) data is an integral function of clinical research, providing the patient perspective that enriches the evaluation of treatment effectiveness. Historically, patient-reported outcomes measurement (PROM) was performed predominantly with paper-based assessments. However, over the past two decades, there has been a notable paradigm shift towards the electronic collection of data." Read more on this topic authored by Dr. Platko

Collecting patient-reported outcome (PRO) data is an integral function of clinical research, providing the patient perspective that enriches the evaluation of treatment effectiveness. Historically, patient-reported outcomes measurement (PROM) was performed predominantly with paper-based assessments....

09/29/2023

https://conta.cc/3rq4yqn

Medical Device News Magazine - Week of September 29, 2023 View as Webpage Share This Email Share This Email Share This Email This Week's News Medical Device News Magazine A Division of PTM Healthcare

09/29/2023

9/29/30: A Platform Approach: Expanding a Molecular Diagnostic Device Beyond Human Applications | By
Shaun Holt, CEO, Alveo Technologies
Holt writes, "Avian flu is a global crisis, and not just for the poultry industry. There are serious potential implications for human health as well. But, let’s start with agriculture. Some strains of avian flu can be highly pathogenic. Once a single bird shows symptoms the clock starts ticking — it’s not unusual for an entire flock of tens of thousands of birds to die within two to three days."

Holt writes, "Avian flu is a global crisis, and not just for the poultry industry. There are serious potential implications for human health as well. But, let’s start with agriculture. Some strains of avian flu can be highly pathogenic. Once a single bird shows symptoms the clock starts ticking .....

09/28/2023

Isothermal mixes are important in a range of isothermal amplification applications, including whole genome amplification, point-of-care assay development and testing, and strand displacement amplification for synthetic biology. However, a common issue with isothermal mixes is non-specific amplificat...

09/19/2023

This article takes a closer look at the key benefits of automation and technology in pharmaceutical manufacturing and how Medivant Healthcare harnesses these solutions to drive progress across our production facilities. Read what Viraj Gandhi has to say.

09/15/2023

This Week's News!
Featuring: It Takes an Ecosystem – Bringing Stakeholders Together is a Critical 1st Step to Solving Problems In Healthcare | By Andrew Cleeland, CEO, Fogarty Innovation https://conta.cc/3sVVb1Y

The Evolution of Vascular Surgery in the Era of AI “The Fifth Cardio-Vascular Revolution.” | By Prof Sherif Sultan, MD FRCS FACS PhD View as Webpage Share This Email Share This Email Share This Email

09/14/2023

Andrew Cleeland writes, "Introducing a new medical therapy or technology is a complex, expensive, and time-consuming journey, one that is fraught with significant risk. While innovation often starts with a clear, well-defined unmet clinical need, it must be paired with an equally compelling value proposition. My mentor, Dr. Thomas Fogarty, once said, “An idea, by itself, has no importance whatsoever; it is the implementation of that idea and its acceptance by others that brings benefit to our patients.” Read more ....

Andrew Cleeland writes, "Introducing a new medical therapy or technology is a complex, expensive, and time-consuming journey, one that is fraught with significant risk. While innovation often starts with a clear, well-defined unmet clinical need, it must be paired with an equally compelling value pr...

09/12/2023

“Immune System is an innovative Open Access journal, welcoming articles with a broad background from basic science to clinical research, as long as the manuscript focuses on certain aspects of our immune response,” states editor-in-chief Désirée Larenas-Linnemann."

09/12/2023

Moshe Zilversmit, Co-Founder and CEO of Signum Surgical, commented: “The completion of our clinical trial marks a significant milestone for Signum Surgical and our BioHealxTM device. We look forward to submitting our De Novo classification request to the U.S. FDA and the scientific publication of ...

09/01/2023

Richard Pellegrino joins Grenova during a period of rapid growth as the company expands its award-winning team designed to make the life sciences industry environmentally friendly, cost-effective, and efficient.

08/23/2023

Dr William A Clementi brings with him a wealth of experience in the biopharmaceutical industry, having held leadership roles at several prominent companies. He has a proven track record of successfully guiding development programs from early stages through clinical trials, regulatory approval, and c...

08/23/2023

BioSig Technologies, Inc. has made the move to a subscription model so that electrophysiologists and cardiology departments can access the latest features with the ability to customize the rich suite of PURE EP™ software capabilities to suit their needs.

BioSig has made the move to a subscription model so that electrophysiologists and cardiology departments can access the latest features with the ability to customize the rich suite of PURE EP™ software capabilities to suit their needs.

08/23/2023

“The granting of this patent is an important component of our strategy to become a leader in the development of drugs that target critical neurodegenerative diseases,” said David Stamler, M.D., Chief Executive Officer of Alterity Therapeutics.